Mark A Milad obtained a BS in Pharmacy from Duquesne University and a Pharm D from Wayne State University before completing a Clinical Pharmacology Fellowship in Pharmacokinetics Pharmacodynamics and Immunology at the State University of New York at Buffalo. After gaining experience at Parke-Davis, Pfizer and Metabasis, Mark started privately consulting for the pharmaceutical industry. Mark has extensive experience applying clinical pharmacology skills and insights to drug development. His work focuses on optimal design of the drug development program by applying PK/PD principles, analysis and simulation. His areas of expertise include: clinical pharmacology, protocol design, project leadership, strategic planning, pharmacokinetic data analysis, population pharmacokinetic and pharmacodynamic analysis, and modeling/simulation. He has preclinical development experience, evaluates compounds for in-licensing, and held leadership roles on development teams.